Cultivation Capital

VedaPointe, established in 2019 and headquartered in St. Louis, Missouri, specializes in facilitating efficient exchange of clinical and administrative healthcare data. The company offers a health-tech platform designed to align communication channels, fostering innovative healthcare economic models. This platform provides a comprehensive data ecosystem that enhances revenue cycle management by integrating clinical and administrative healthcare data, thereby enabling healthcare professionals to access strategic expertise and derive new value from this integrated data.

Clever Real Estate is a company that specializes in commercial real estate and online marketplaces. It offers a software platform that guides users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St. Louis, Missouri.

SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making in complex environments. Founded in 2018, the company offers solutions that optimize and accelerate processes such as scheduling, production planning, and portfolio optimization. By leveraging advanced algorithmic innovations, SimpleRose’s platform provides high levels of numerical accuracy, speed, and the capability for continuous analysis, enabling organizations to effectively address operational challenges and make informed decisions.

Mission Control GG, Inc. is a mobile application designed to facilitate recreational esports leagues for gamers, akin to local adult sports leagues. Established in 2018 and headquartered in Saint Louis, Missouri, the platform allows users to join leagues with friends or participate in those organized by local entities. Mission Control provides comprehensive league management solutions, including scheduling, score validation, and champion determination. It also serves as a forum for league members, enhancing community engagement. Organizations such as community groups, colleges, and LAN centers can utilize Mission Control to host various game titles, attract participants, and streamline their esports operations, fostering a vibrant gaming community.

iSite Media, LLC is a St. Louis-based company specializing in advertising and marketing services through innovative digital display technology. Established in 2015 and formerly known as Sitting Duck Advertising, the company focuses on delivering impactful brand promotions via a digital display network situated in restrooms. This unique positioning enables iSite Media to effectively engage consumers in a private setting, enhancing message recall and relevance. By leveraging location flexibility, the company bridges the gap between content and consumer, ensuring that advertising reaches the appropriate audience in a compelling manner. Since its inception, iSite Media has prioritized high-level engagement, recognizing the importance of targeting the right viewers for successful media campaigns. In 2017, it rebranded to underscore its commitment to modern advertising solutions.

Geneoscopy develops non-invasive diagnostics using stool-derived eukaryotic RNA to prevent, detect, and guide treatment for gastrointestinal diseases. Its platform technology enables early-stage detection of colorectal cancer neoplasms and improves screening compliance.

Clever Real Estate is a company that specializes in commercial real estate and online marketplaces. It offers a software platform that guides users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St. Louis, Missouri.

Balto develops AI-powered real-time guidance and conversation analytics for contact centers. Its SaaS platform listens to live calls and provides instant prompts, tips, and corrective suggestions to sales and service agents to identify pain signals, handle objections, and balance talk time, with dashboards for managers to monitor performance and compliance. The solution aims to prevent missed opportunities and costly compliance mistakes by guiding agents during calls and flagging non-compliant language. The platform serves sales, customer service, accounts receivable, and compliance quality use cases. Balto was founded in 2017 and is based in Saint Louis, Missouri.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

iSite Media, LLC is a St. Louis-based company specializing in advertising and marketing services through innovative digital display technology. Established in 2015 and formerly known as Sitting Duck Advertising, the company focuses on delivering impactful brand promotions via a digital display network situated in restrooms. This unique positioning enables iSite Media to effectively engage consumers in a private setting, enhancing message recall and relevance. By leveraging location flexibility, the company bridges the gap between content and consumer, ensuring that advertising reaches the appropriate audience in a compelling manner. Since its inception, iSite Media has prioritized high-level engagement, recognizing the importance of targeting the right viewers for successful media campaigns. In 2017, it rebranded to underscore its commitment to modern advertising solutions.

Textel CX Inc., established in 2014 and headquartered in Saint Louis, Missouri, specializes in developing a cloud-based texting platform for contact centers and businesses. Its primary product, Textel, enables these entities to engage with customers via text, enhancing customer experience and increasing engagement. Key features include landline texting, API integrations, and a text-to-find service, catering to industries such as car dealerships, insurance, healthcare, and retail. Textel serves nearly 800 customers across North America, facilitating inbound/outbound SMS and MMS texts, and integrating with leading systems of record.

FinLocker, LLC is a financial technology company based in St. Louis, Missouri, founded in 2014. It specializes in developing a consumer-enabled financial data platform that enhances the loan process for mortgages and various financial products. FinLocker provides a personal financial assistant tool that captures essential borrower data with consumer consent, utilizing intelligent analytics to offer tailored loan product recommendations based on individual financial profiles. Its solutions aim to streamline lending processes by improving data collection, verification, and analytics, thereby reducing costs, time, and risks for lenders. Additionally, FinLocker enhances the borrower experience by enabling consumers to manage their finances more effectively, apply for loans with reduced documentation hassles, and control data sharing.

Balto develops AI-powered real-time guidance and conversation analytics for contact centers. Its SaaS platform listens to live calls and provides instant prompts, tips, and corrective suggestions to sales and service agents to identify pain signals, handle objections, and balance talk time, with dashboards for managers to monitor performance and compliance. The solution aims to prevent missed opportunities and costly compliance mistakes by guiding agents during calls and flagging non-compliant language. The platform serves sales, customer service, accounts receivable, and compliance quality use cases. Balto was founded in 2017 and is based in Saint Louis, Missouri.

Mission Control GG, Inc. is a mobile application designed to facilitate recreational esports leagues for gamers, akin to local adult sports leagues. Established in 2018 and headquartered in Saint Louis, Missouri, the platform allows users to join leagues with friends or participate in those organized by local entities. Mission Control provides comprehensive league management solutions, including scheduling, score validation, and champion determination. It also serves as a forum for league members, enhancing community engagement. Organizations such as community groups, colleges, and LAN centers can utilize Mission Control to host various game titles, attract participants, and streamline their esports operations, fostering a vibrant gaming community.

iSite Media, LLC is a St. Louis-based company specializing in advertising and marketing services through innovative digital display technology. Established in 2015 and formerly known as Sitting Duck Advertising, the company focuses on delivering impactful brand promotions via a digital display network situated in restrooms. This unique positioning enables iSite Media to effectively engage consumers in a private setting, enhancing message recall and relevance. By leveraging location flexibility, the company bridges the gap between content and consumer, ensuring that advertising reaches the appropriate audience in a compelling manner. Since its inception, iSite Media has prioritized high-level engagement, recognizing the importance of targeting the right viewers for successful media campaigns. In 2017, it rebranded to underscore its commitment to modern advertising solutions.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Textel CX Inc., established in 2014 and headquartered in Saint Louis, Missouri, specializes in developing a cloud-based texting platform for contact centers and businesses. Its primary product, Textel, enables these entities to engage with customers via text, enhancing customer experience and increasing engagement. Key features include landline texting, API integrations, and a text-to-find service, catering to industries such as car dealerships, insurance, healthcare, and retail. Textel serves nearly 800 customers across North America, facilitating inbound/outbound SMS and MMS texts, and integrating with leading systems of record.

Healthy Bytes, Inc. is a healthcare company that specializes in personalized nutritional counseling through its innovative platform. Founded in 2014 and headquartered in Saint Louis, Missouri, with an additional office in New York, Healthy Bytes connects registered dietitians with employers to provide nutritional support for employees dealing with health issues such as obesity, diabetes, high blood pressure, and cardiovascular diseases. The platform facilitates private consultations, allowing users to book appointments with registered dietitians online. By utilizing their existing medical benefits, employees can access nutritional counseling at no additional cost, empowering them to lead healthier lifestyles. The company's approach enables dietitians to gain insight into their clients' eating habits, fostering more effective and tailored guidance.

Geneoscopy develops non-invasive diagnostics using stool-derived eukaryotic RNA to prevent, detect, and guide treatment for gastrointestinal diseases. Its platform technology enables early-stage detection of colorectal cancer neoplasms and improves screening compliance.

Balto develops AI-powered real-time guidance and conversation analytics for contact centers. Its SaaS platform listens to live calls and provides instant prompts, tips, and corrective suggestions to sales and service agents to identify pain signals, handle objections, and balance talk time, with dashboards for managers to monitor performance and compliance. The solution aims to prevent missed opportunities and costly compliance mistakes by guiding agents during calls and flagging non-compliant language. The platform serves sales, customer service, accounts receivable, and compliance quality use cases. Balto was founded in 2017 and is based in Saint Louis, Missouri.

Clever Real Estate is a company that specializes in commercial real estate and online marketplaces. It offers a software platform that guides users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St. Louis, Missouri.

Well Principled Corp. is an artificial intelligence management consulting firm based in St. Louis, Missouri, specializing in optimizing marketing and supply chain strategies for retail and consumer packaged goods (CPG) brands. Founded in 2018, the company leverages advanced algorithmic technology to predict customer buying behavior and provide actionable insights derived from established business theories and contemporary AI methodologies. Well Principled offers a streamlined alternative to traditional optimization methods that often rely on extensive analyst teams and custom development projects. Its software integrates diverse data sources to identify key business drivers, enabling clients to enhance customer retention, refine pricing strategies, and improve overall operational efficiency. By delivering clear, theory-backed plans of action, Well Principled empowers organizations to achieve growth and better manage their marketing and supply chain processes.

Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Founded in 2006 and headquartered in Brisbane, California, with a scientific research laboratory in St. Louis, Missouri, the company is known for its innovative approach to cancer treatment. Arch Oncology specializes in anti-CD47 antibodies, which represent a new class of checkpoint inhibitors that engage both the adaptive and innate immune responses. These functionally diverse antibodies not only inhibit immune checkpoints but also selectively target and kill tumor cells, providing patients with new therapeutic options in the fight against cancer.

Founded in 2016, Aggio develops cloud-based sales applications tailored for the agriculture industry. Its platform harmonizes multiple data sources, providing actionable insights for marketing and sales teams to engage customers and channel partners effectively.

Clever Real Estate is a company that specializes in commercial real estate and online marketplaces. It offers a software platform that guides users through the process of interviewing real estate agents to find the right one for them. The company was founded in 2017 and is headquartered in St. Louis, Missouri.

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

SimpleRose Inc. is a technology company based in Saint Louis, Missouri, that specializes in developing a prescriptive analytics platform aimed at enhancing decision-making in complex environments. Founded in 2018, the company offers solutions that optimize and accelerate processes such as scheduling, production planning, and portfolio optimization. By leveraging advanced algorithmic innovations, SimpleRose’s platform provides high levels of numerical accuracy, speed, and the capability for continuous analysis, enabling organizations to effectively address operational challenges and make informed decisions.

iSite Media, LLC is a St. Louis-based company specializing in advertising and marketing services through innovative digital display technology. Established in 2015 and formerly known as Sitting Duck Advertising, the company focuses on delivering impactful brand promotions via a digital display network situated in restrooms. This unique positioning enables iSite Media to effectively engage consumers in a private setting, enhancing message recall and relevance. By leveraging location flexibility, the company bridges the gap between content and consumer, ensuring that advertising reaches the appropriate audience in a compelling manner. Since its inception, iSite Media has prioritized high-level engagement, recognizing the importance of targeting the right viewers for successful media campaigns. In 2017, it rebranded to underscore its commitment to modern advertising solutions.

FinLocker, LLC is a financial technology company based in St. Louis, Missouri, founded in 2014. It specializes in developing a consumer-enabled financial data platform that enhances the loan process for mortgages and various financial products. FinLocker provides a personal financial assistant tool that captures essential borrower data with consumer consent, utilizing intelligent analytics to offer tailored loan product recommendations based on individual financial profiles. Its solutions aim to streamline lending processes by improving data collection, verification, and analytics, thereby reducing costs, time, and risks for lenders. Additionally, FinLocker enhances the borrower experience by enabling consumers to manage their finances more effectively, apply for loans with reduced documentation hassles, and control data sharing.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Aptimmune is a biotechnology company headquartered in St. Louis, Missouri, established in 2010. It specializes in the development of mucosal vaccines aimed at preventing viral diseases in swine, specifically targeting the Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza A virus. By employing innovative technologies, including a proprietary pig alveolar macrophage cell line known as ZMAC, Aptimmune creates effective nasal delivery vaccines that provide lasting immune responses and enhance disease protection for animal breeders.

SentiAR is a digital health software company developing a 3D augmented reality holographic platform that provides real-time visualization of a patient’s anatomy and catheter location during interventional procedures. Spun out from Washington University, it uses real-time mapping data and imaging from CT/MRI to render holographic views over the patient in the catheterization laboratory, with clinician-controlled visualization. The platform aims to improve precision and safety in procedures addressing cardiac arrhythmias. The company focuses on delivering an immersive visualization solution for interventional cardiology and related specialties.

Noonlight, Inc. is a personal safety technology company that develops a mobile application designed to enhance user safety by connecting various Internet of Things (IoT) devices. Founded in 2013 and headquartered in Saint Louis, Missouri, Noonlight's application enables users to create accounts, connect their devices, and sense potential danger. The platform offers a seamless experience across iOS and Android devices, allowing for precise location detection and the ability to trigger alarms manually. In emergency situations, the application can alert law enforcement without requiring a 911 call or the need for users to communicate verbally. Noonlight has evolved into a comprehensive connected safety platform, partnering with various products and services to provide 24/7 professional monitoring and data-driven emergency response, ensuring users can feel secure in any environment.

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

FinLocker, LLC is a financial technology company based in St. Louis, Missouri, founded in 2014. It specializes in developing a consumer-enabled financial data platform that enhances the loan process for mortgages and various financial products. FinLocker provides a personal financial assistant tool that captures essential borrower data with consumer consent, utilizing intelligent analytics to offer tailored loan product recommendations based on individual financial profiles. Its solutions aim to streamline lending processes by improving data collection, verification, and analytics, thereby reducing costs, time, and risks for lenders. Additionally, FinLocker enhances the borrower experience by enabling consumers to manage their finances more effectively, apply for loans with reduced documentation hassles, and control data sharing.

BlueStrata EHR is a St. Louis-based company that specializes in developing a cloud-based electronic health records software platform tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, ensuring seamless data sharing across medical records and billing systems. BlueStrata EHR's intuitive design includes conveniently located touch screen kiosks, enabling caregivers to accurately capture resident care information from any location. Since August 1, 2018, the company has operated as a subsidiary of Mediware Information Systems, Inc., enhancing its capabilities in meeting contemporary healthcare standards.

Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Founded in 2006 and headquartered in Brisbane, California, with a scientific research laboratory in St. Louis, Missouri, the company is known for its innovative approach to cancer treatment. Arch Oncology specializes in anti-CD47 antibodies, which represent a new class of checkpoint inhibitors that engage both the adaptive and innate immune responses. These functionally diverse antibodies not only inhibit immune checkpoints but also selectively target and kill tumor cells, providing patients with new therapeutic options in the fight against cancer.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

Noonlight, Inc. is a personal safety technology company that develops a mobile application designed to enhance user safety by connecting various Internet of Things (IoT) devices. Founded in 2013 and headquartered in Saint Louis, Missouri, Noonlight's application enables users to create accounts, connect their devices, and sense potential danger. The platform offers a seamless experience across iOS and Android devices, allowing for precise location detection and the ability to trigger alarms manually. In emergency situations, the application can alert law enforcement without requiring a 911 call or the need for users to communicate verbally. Noonlight has evolved into a comprehensive connected safety platform, partnering with various products and services to provide 24/7 professional monitoring and data-driven emergency response, ensuring users can feel secure in any environment.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.

FinLocker, LLC is a financial technology company based in St. Louis, Missouri, founded in 2014. It specializes in developing a consumer-enabled financial data platform that enhances the loan process for mortgages and various financial products. FinLocker provides a personal financial assistant tool that captures essential borrower data with consumer consent, utilizing intelligent analytics to offer tailored loan product recommendations based on individual financial profiles. Its solutions aim to streamline lending processes by improving data collection, verification, and analytics, thereby reducing costs, time, and risks for lenders. Additionally, FinLocker enhances the borrower experience by enabling consumers to manage their finances more effectively, apply for loans with reduced documentation hassles, and control data sharing.

Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Euphrates Vascular is a medical technology company based in St. Louis, Missouri, that focuses on innovative solutions for the treatment of stroke, heart disease, and other conditions. The company has developed a proprietary magnetically-enhanced diffusion (MED) system that utilizes magnet-based technology to dissolve blood clots more rapidly than existing treatment options. This system aims to improve the efficacy of FDA-approved clot-busting medications, potentially reducing mortality rates associated with stroke and cardiovascular diseases. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which are designed to deliver therapeutic agents directly to clots during thrombolysis therapy, and a touch screen-operated MED Workstation. Founded by physicists with extensive experience in medical technology, the company continues to advance its pioneering approaches in the healthcare sector, attracting interest from investors and media alike.

Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

BlueStrata EHR is a St. Louis-based company that specializes in developing a cloud-based electronic health records software platform tailored for long-term care and resident care facilities. The platform integrates clinical, financial, and point-of-care services, ensuring seamless data sharing across medical records and billing systems. BlueStrata EHR's intuitive design includes conveniently located touch screen kiosks, enabling caregivers to accurately capture resident care information from any location. Since August 1, 2018, the company has operated as a subsidiary of Mediware Information Systems, Inc., enhancing its capabilities in meeting contemporary healthcare standards.

Arch Oncology, Inc. is an immuno-oncology company focused on discovering and developing antibody therapeutics for the treatment of solid tumors and hematologic cancers. Founded in 2006 and headquartered in Brisbane, California, with a scientific research laboratory in St. Louis, Missouri, the company is known for its innovative approach to cancer treatment. Arch Oncology specializes in anti-CD47 antibodies, which represent a new class of checkpoint inhibitors that engage both the adaptive and innate immune responses. These functionally diverse antibodies not only inhibit immune checkpoints but also selectively target and kill tumor cells, providing patients with new therapeutic options in the fight against cancer.

Founded in 2011 and headquartered in St. Louis, Missouri, Tunespeak operates a musician-to-fan loyalty platform. Its platform enables users to earn points by engaging with music content such as listening to songs, watching videos, browsing photos, and sharing with friends.

CoverCress Inc. specializes in developing and commercializing field pennycress as a sustainable oilseed crop for industrial oils and livestock feed. Founded in 2013, the company is headquartered in Saint Louis, Missouri.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Adarza BioSystems is an early-stage medical diagnostics company based in St. Louis, Missouri, that specializes in developing a rapid and label-free biological assay platform for clinical and point-of-care samples. Founded in 2008, the company utilizes its innovative arrayed imaging reflectometry technology to enable the simultaneous detection of hundreds of analytes from a single drop of fluid. This platform allows healthcare professionals to conduct sophisticated tests in a matter of minutes, ensuring high sensitivity and specificity in the detection of multiplexed proteins. Adarza BioSystems aims to enhance diagnostic capabilities, improving patient outcomes through quicker and more accurate testing.

Founded in 2011 and headquartered in St. Louis, Missouri, Tunespeak operates a musician-to-fan loyalty platform. Its platform enables users to earn points by engaging with music content such as listening to songs, watching videos, browsing photos, and sharing with friends.

Wealth Access, Inc. is a financial technology company that specializes in personal financial management tools for registered investment advisors and their high-net-worth clients. Founded in 2011 and headquartered in Nashville, Tennessee, the company offers a proprietary cloud-based wealth reporting and investment monitoring platform. This platform features an intuitive interface, advanced aggregation capabilities, and the ability to manage over 20,000 data feeds from various financial institutions. Wealth Access aims to simplify complex global portfolios by presenting data in a clear, real-time digital dashboard, thereby enhancing the wealth management experience for financial advisors and their clients. The company also has operational locations in St. Louis, Missouri; Dallas, Texas; New York, New York; and Tampa, Florida.

Euphrates Vascular is a medical technology company based in St. Louis, Missouri, that focuses on innovative solutions for the treatment of stroke, heart disease, and other conditions. The company has developed a proprietary magnetically-enhanced diffusion (MED) system that utilizes magnet-based technology to dissolve blood clots more rapidly than existing treatment options. This system aims to improve the efficacy of FDA-approved clot-busting medications, potentially reducing mortality rates associated with stroke and cardiovascular diseases. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which are designed to deliver therapeutic agents directly to clots during thrombolysis therapy, and a touch screen-operated MED Workstation. Founded by physicists with extensive experience in medical technology, the company continues to advance its pioneering approaches in the healthcare sector, attracting interest from investors and media alike.

Mobius Therapeutics develops sterile injectable pharmaceutical products for ophthalmic applications. Its flagship product is Mitosol, a closed-system transfer device containing mitomycin for solution, used by ophthalmologists to prevent scarring during glaucoma, refractive, and corneal surgeries.

Aisle411 Inc., founded in 2008 and based in St. Louis, Missouri, offers a mobile in-store location services platform for retailers. The company's platform enables shoppers to easily navigate retail stores by mapping products, offers, and lists by aisle location, providing unique information based on the shopper’s in-store location. This enhances the shopping experience by allowing retailers to reach shoppers at the shelf with contextually relevant information. Aisle411 collects, organizes, and monetizes retailers’ product inventory, location data, and enterprise software space planning systems and store maps. The company has partnered with leading indoor positioning technology providers to offer shopper positioning services that drive merchandising insights and engaging shopping experiences, ultimately increasing customer satisfaction and retailer engagement.

Founded in 2011 and headquartered in St. Louis, Missouri, Tunespeak operates a musician-to-fan loyalty platform. Its platform enables users to earn points by engaging with music content such as listening to songs, watching videos, browsing photos, and sharing with friends.

Label Insight, Inc. is a St. Louis-based company that specializes in a cloud-based product data engine designed to help brands and retailers manage and understand their product data. Founded in 2004, the company collects, aggregates, and analyzes a wide range of information from product packaging, including descriptions, nutrients, ingredients, allergens, marketing claims, and certifications. This comprehensive data allows CPG brands, retailers, and food industry stakeholders to compare and analyze products across various categories, such as food and beverage, apparel, personal care, and electronics. By transforming basic product information into detailed attributes, Label Insight empowers companies to unlock growth opportunities and enhances consumer decision-making by providing greater transparency regarding product contents. The company also has an operational presence in Canada and a secondary office in Chicago, Illinois.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Aisle411 Inc., founded in 2008 and based in St. Louis, Missouri, offers a mobile in-store location services platform for retailers. The company's platform enables shoppers to easily navigate retail stores by mapping products, offers, and lists by aisle location, providing unique information based on the shopper’s in-store location. This enhances the shopping experience by allowing retailers to reach shoppers at the shelf with contextually relevant information. Aisle411 collects, organizes, and monetizes retailers’ product inventory, location data, and enterprise software space planning systems and store maps. The company has partnered with leading indoor positioning technology providers to offer shopper positioning services that drive merchandising insights and engaging shopping experiences, ultimately increasing customer satisfaction and retailer engagement.

Euphrates Vascular is a medical technology company based in St. Louis, Missouri, that focuses on innovative solutions for the treatment of stroke, heart disease, and other conditions. The company has developed a proprietary magnetically-enhanced diffusion (MED) system that utilizes magnet-based technology to dissolve blood clots more rapidly than existing treatment options. This system aims to improve the efficacy of FDA-approved clot-busting medications, potentially reducing mortality rates associated with stroke and cardiovascular diseases. In addition to the MED system, Euphrates Vascular offers MED MicroBeads, which are designed to deliver therapeutic agents directly to clots during thrombolysis therapy, and a touch screen-operated MED Workstation. Founded by physicists with extensive experience in medical technology, the company continues to advance its pioneering approaches in the healthcare sector, attracting interest from investors and media alike.